Soft Tissue Allograft Market by Type (Meniscus Allograft, Cartilage Allograft, Tendon Allograft, Dental Allograft, Others); by Applications (Dentistry, Orthopaedic, Wound Care, Others); by End User (Aesthetic Centres, Dental Clinics, Orthopaedic Clinic, Hospitals, Others); by Region (North America, Europe, Asia-pacific, Latin America, Middle East Africa): Global Forecasts 2021 To 2027

The Global Soft Tissue Allograft Market size was valued at USD 3.6 Bn by 2020 and is expected to reach USD 5.5 Bn by 2027, with a growing CAGR of 6.4 % during the forecast period.

Market Definition

Soft tissue allograft is the surgical procedure that uses tissue from a donor or animal (tissue of another person) to treat ligament, dental or musculoskeletal problems. Soft tissue allograft offers greater graft availability, greater expansion of their use by surgeons, and reduces morbidity in joints reconstruction procedures. Factors such as aging, bone dislocate, trauma, bone breakage, poor tooth positioning, and periodontal diseases elevate the need for soft tissue allograft.

Soft Tissue Allograft Market Size

Market Dynamics

The driving factors for global soft tissue allograft market include rise in prevalence of dental diseases and orthopaedic problems such as bone breakage, bone dislocate, rising geriatric population and growing technological advances in allograft. Moreover, increasing consumption of alcohol and smoking, rising demand for tissue allograft procedures and growing awareness regarding soft tissue allograft fuels the growth of soft tissue allograft market.

Growing advances in medical procedures, rising demand for soft tissue allografts in athletic patients and increasing focus of pharmaceutical and biotechnological companies towards soft tissue replacement techniques leverage the growth of soft tissue allograft market. In addition to this, increasing use of allograft tissue in organized collection, sterilization procedures and increasing stability of allografts further boost the growth of soft tissue allograft market.

Growing insights regarding allograft utilization, management, sterilization and regulation uplifts the growth of soft tissue allograft market. However, the challenges such as need for biomechanical functionality and tissue sterility forbid the growth of soft tissue allograft market. High treatment cost and poor reimbursement policies restrain the growth of soft tissue allograft market.

Global Soft Tissue Allograft Market Segmentation:

By Type

  • Meniscus Allograft
  • Cartilage Allograft
  • Tendon Allograft
  • Dental Allograft
  • Others

By Application

  • Dentistry
  • Orthopaedic
  • Wound Care
  • Others

By End User

  • Aesthetic Centres
  • Dental Clinics
  • Orthopaedic Clinic
  • Hospitals
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Based on type, cartilage allograft accounted for the highest market share in 2020 owing to increase in number of geriatric patients associated with joint complications

Based on type, soft tissue allograft market is segmented into meniscus allograft, cartilage allograft, tendon allograft and dental allograft. Cartilage allograft segment held largest market share in 2020 due to increase in its applications in bone replacement. Moreover, increase in osteoarthritis diseases, growing rate of accidents and increasing wear & tear of cartilage tissue further boost the growth of soft tissue allograft market.

On the contrary, dental allograft segment is expected to witness fastest growth with highest CAGR owing to increase in dental diseases. Moreover, increase in geriatric population, rising oral cavities and growing cases of periodontal diseases further fuels the growth of dental allograft market.

Based on application, orthopaedic segment held the largest market share in 2020 due to growing bone disorders in the population

Based on applications, soft tissue allograft market is segmented into aesthetic centres, dental clinics, orthopaedic clinic, and hospitals. Orthopaedic segment accounted for highest market share in 2020 and expected to increase more during forecast period due to growing incidences in life, rising geriatric population, increasing life expectancy, and rising consumer perception towards minimal invasive clinical procedures boost the growth of soft tissue allograft market.

However, dental application of soft tissue allograft market is expected to witness fastest growth with highest CAGR due to increasing number of patients associated with dental treatments. Moreover, increasing oral cancer, teeth decay and ever-growing geriatric population trigger the growth of soft tissue allograft market.

Based on end user, hospital segment held largest market share in 2020 due to high number of patient admission and presence of complete patient care

Based on end user, soft tissue allograft market is segmented into aesthetic centres, dental clinics, orthopaedic clinic, and hospitals. Hospital accounted for the largest market share in 2020 due to presence of treatment reimbursement policies and availability of complete patient care in the hospital. Moreover, availability of trained healthcare professionals & surgeons in the hospital and other healthcare facilities fuels the growth soft tissue allograft market.

Based on geographical region, North America dominated the market in 2020 due to presence well-established healthcare infrastructure

Based on region, North America dominated the growth of market in 2020 and is expected to maintain same dominance during forecast period. This is due to availability of key market players and strong government support for research. Moreover, rising awareness regarding allografting procedures, growing oral health concern and growing number of dental visits in this region fuels the growth of soft tissue allograft market.

Company Profiles and Competitive Intelligence

The key players operating in the soft tissue allograft market are:

  • Lattice Biologics Ltd.
  • AlonSource Group
  • CONMED Corporation
  • Zimmer Biomet
  • MiMedix Group
  • AlloSource
  • Osiris Therapeutics
  • Organogenesis, Inc.
  • RTI Surgical, Inc.
  • Integra LifeSciences Corporation
  • Alliqua BioMedical, Inc.
  • Globus Medical, Inc.
  • Straumann Holding AG
  • Arthrex.
  • Xtant Medical
  • Abbvie inc.
  • Smith & Nephew
  •  Becton Dickinson and Company,
  • Integra LifeSciences Corporation,
  •  Stryker Corporation,
  •  Direct Biologics
  • C. R. Bard, Inc. (Davol, Inc.)
  • B. Braun Melsungen

The report also provides in-depth analysis of soft tissue allograft market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Growing advances in medical technology
  • Growing aging population
  • Increasing clinical allograft procedures
  • Growing awareness regarding soft tissue allograft techniques
  • Gaining clinical success in soft tissue reconstruction procedures

Restraints

  • Poor reimbursement policies
  • Inflated cost of allograft procedures restrains the growth of soft tissue allograft market

Opportunity

  • Emergence of key players in the market
  • Growing need demand for allografts among athletics creates opportunity for the growth of soft tissue allograft market

Challenges  

  • Lack of biomechanical functionality
  • Less tissue sterility is the major challenge faced by the companies in soft tissue allograft market

COVID-19 Impact on the Soft Tissue Allograft Market Analysis

Covid-19 has highly affected the industries in terms of growth, economy, health, and mental wellbeing of every individual. In this challenging situation, every industry is trying to give best services in terms of quality and safety. Covid-19 has poorly impacted the growth of soft tissue allograft market. During covid-19, priority was given to the covid infected patients wherein surgeries related to the allograft was kept on hold.

There was decrease in availability of surgeons and healthcare professionals for the allografting procedures. This affected the growth of soft tissue allograft market across the globe. Moreover, there was decline in number of tissue donation or donors for allograft procedures due to high risk of infection transfer. This factor proven to be the major pitfall for the growth of soft tissue allograft market.

The report also provides an in-depth analysis of key trends in soft tissue allograft market

  • Emergence of new technology in creation and isolation of human bone morphogenic proteins and growth factors are the emerging trends in bone grafting procedures
  • Growing investment in healthcare, rising research and development in allografting and increasing disposable income
  • Covid-19 outbreak has poorly impacted the growth of soft tissue allograft market due to sudden decline in number of donations/donors for the tissue.

The report also provides an in-depth analysis of recent news developments and investments

  • In January 2021, Direct Biologics launched AmnioWrap™ placental-based sheet allograft for clinical use. AmnioWrap™ is used in acute and chronic wounds. AmnioWrap will expand product portfolio of the company by delivering the solutions for patients in need to the newest generation therapy.
  • In October 2020, BioStem Technologies, Inc launched AEON™ in the market. AEON™ is natural amniotic fluid allograft that is aseptically processed and sterilized using e-beam irradiation. This product contributes to the expansion of company’s portfolio and business.  

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Soft Tissue Allograft Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global market was valued at USD 3.6 Bn in 2020 and is anticipated to reach USD 5.5 Bn by 2027

The global market is estimated to grow at a compound annual growth rate (CAGR) of 6.4% during forecast period

In the base year 2020, North America accounted for the maximum share in the market.

Lack reimbursement policies and high treatment cost restraint the growth of market.

As per expert opinions, growing awareness regarding tissue allograft, rising geriatric population, advances in medical technology and increasing clinical allograft procedures will drive the growth market.

Few key players include, but not limit up to: Lattice Biologics Ltd., CONMED Corporation, AlonSource Group, MiMedix Group, Zimmer Biomet, Integra LifeSciences Corporation, AlloSource, Alliqua BioMedical, Inc, Osiris Therapeutics and RTI Surgical, Inc.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Soft Tissue Allograft Market?
    3. Analysis of Soft Tissue Allograft Market
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Soft Tissue Allograft Market
    1. Regulations and Standards
  3. Soft Tissue Allograft Market by Type
    1. Meniscus Allograft
    2. Cartilage Allograft
    3. Tendon Allograft
    4.  Dental Allograft
    5.  Others
  4. Soft Tissue Allograft Market by Applications
    1. Dentistry
    2.  Orthopaedic
    3. Wound Care
    4. Others
  5. Soft Tissue Allograft Market by End User
    1. Aesthetic Centres
    2.  Dental Clinics
    3.  Orthopaedic Clinic
    4.  Hospitals
    5.  Others
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Netherlands
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Colombia
      3. Rest of Latin America
    5. Middle East Africa (MEA)
      1. South Africa
      2. Rest of MEA
  7. Key Strategic Insights
  8. Market Analysis
    1. New Applications
    2. Emerging Technologies
    3. Opportunity Mapping
    4. Critical Success Factors
    5. Consumer Preferences
  9. Key Market Trends / Recent Developments
  10. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product launches
    5. Ranking of Key Players
    6. Presence of players by Geographies
  11. Key global players
    1. Lattice Biologics Ltd.
    2. AlonSource Group
    3. CONMED Corporation
    4. Zimmer Biomet
    5. MiMedix Group
    6. AlloSource
    7. Osiris Therapeutics
    8. Organogenesis, Inc.
    9. RTI Surgical, Inc.
    10. Integra LifeSciences Corporation
    11. Alliqua BioMedical, Inc.
    12. Globus Medical, Inc.
    13. Straumann Holding AG
    14. Arthrex
    15. Xtant Medical

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization